Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models
Xiaoxiao He, … , Ye Yu, Junke Zheng
Xiaoxiao He, … , Ye Yu, Junke Zheng
Published December 10, 2020
Citation Information: J Clin Invest. 2021;131(4):e140242. https://doi.org/10.1172/JCI140242.
View: Text | PDF
Research Article Hematology

Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models

  • Text
  • PDF
Abstract

How particular bone marrow niche factors contribute to the leukemogenic activities of leukemia-initiating cells (LICs) remains largely unknown. Here, we showed that ATP levels were markedly increased in the bone marrow niches of mice with acute myeloid leukemia (AML), and LICs preferentially localized to the endosteal niche with relatively high ATP levels, as indicated by a sensitive ATP indicator. ATP could efficiently induce the influx of ions into LICs in an MLL-AF9–induced murine AML model via the ligand-gated ion channel P2X7. P2x7 deletion led to notably impaired homing and self-renewal capacities of LICs and contributed to an approximately 5-fold decrease in the number of functional LICs but had no effect on normal hematopoiesis. ATP/P2X7 signaling enhanced the calcium flux–mediated phosphorylation of CREB, which further transactivated phosphoglycerate dehydrogenase (Phgdh) expression to maintain serine metabolism and LIC fates. P2X7 knockdown resulted in a markedly extended survival of recipients transplanted with either human AML cell lines or primary leukemia cells. Blockade of ATP/P2X7 signaling could efficiently inhibit leukemogenesis. Here, we provide a perspective for understanding how ATP/P2X7 signaling sustains LIC activities, which may benefit the development of specific strategies for targeting LICs or other types of cancer stem cells.

Authors

Xiaoxiao He, Jiangbo Wan, Xiaona Yang, Xiuze Zhang, Dan Huang, Xie Li, Yejun Zou, Chiqi Chen, Zhuo Yu, Li Xie, Yaping Zhang, Ligen Liu, Shangang Li, Yuzheng Zhao, Hongfang Shao, Ye Yu, Junke Zheng

×

Figure 2

P2X7 is highly expressed in LICs and promotes AML development.

Options: View larger image (or click on image) Download as PowerPoint
P2X7 is highly expressed in LICs and promotes AML development.
(A and B)...
(A and B) mRNA levels of P2x1–P2x7 were determined in the immunophenotypic Mac-1+c-Kit+ LICs (A) or Lin–Sca-1–c-Kit+CD34+CD16/32– L-GMPs (B) by quantitative RT-PCR (n = 3). (C) mRNA levels of P2Xs were analyzed in cells of AML patients from TCGA database (n = 179). (D) mRNA levels of P2x7 in normal mouse bone marrow cells (Normal-BM), Lin–Sca-1+c-Kit+CD34–Flk2– long-term HSCs (LT-HSCs), Lin–Sca-1+c-Kit+CD34+Flk2+ short-term HSCs (ST-HSCs), YFP+ leukemia cells (AML-BM), Mac-1+c-Kit+ LICs, and Lin–Sca-1–c-Kit+CD34+CD16/32– L-GMPs were measured by quantitative RT-PCR (n = 3). (E) P2X7-mediated influx of ions in murine Mac-1+c-Kit+ LICs cells was measured upon sequential treatments with extracellular ATP and P2X7 antagonist A-740003 by whole-cell patch-clamp recording (n = 3). (F) Nucleotide base sequences deleted in the P2x7-knockout (P2x7-KO or P2x7-null) mouse using the CRISPR-Cas9 strategy. (G) mRNA level of P2x7 in WT and P2x7-KO BM cells was measured by quantitative RT-PCR (n = 3). ***P < 0.001 by Student’s t test. (H) P2X7 protein levels in WT and P2x7-KO BM cells were measured by Western blot. (I) Representative flow cytometric analysis of leukemia cells (YFP+) in the peripheral blood upon primary transplantation. (J) Quantification of data in panel I (n = 5). PB, peripheral blood. **P < 0.01 by Student’s t test. (K) The overall survival of the recipient mice transplanted with WT or P2x7-KO MLL-AF9+ BM cells upon primary transplantation (n = 5). ***P < 0.001 by log-rank test. (L) Representative images of the size of spleens and livers of recipients upon primary transplantation. (M) Quantification of data in panel L (n = 4). *P < 0.05, **P < 0.01 by 2-way ANOVA with Sidak’s multiple-comparison test. (N) The overall survival of recipient mice transplanted with WT or P2x7-KO MLL-AF9+ BM cells upon secondary transplantation (n = 5). ***P < 0.001 by log-rank test. (O) Limiting dilution assays for the frequency of the functional LICs of WT and P2x7-KO BM cells. Experiments were repeated independently 3 times.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts